PT Pyridam Farma Tbk (ISX:PYFA) EV-to-EBIT : -62.87 (As of May. 30, 2025)

View and export this data going back to 2001. Start your Free Trial

What is PT Pyridam Farma Tbk EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PT Pyridam Farma Tbk's Enterprise Value is Rp6,075,449 Mil. PT Pyridam Farma Tbk's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was Rp-96,638 Mil. Therefore, PT Pyridam Farma Tbk's EV-to-EBIT for today is -62.87.

The historical rank and industry rank for PT Pyridam Farma Tbk's EV-to-EBIT or its related term are showing as below:

ISX:PYFA' s EV-to-EBIT Range Over the Past 10 Years
Min: -127.41 Med: 10.14 Max: 566.33
Current: -62.87

During the past 13 years, the highest EV-to-EBIT of PT Pyridam Farma Tbk was 566.33. The lowest was -127.41. And the median was 10.14.

ISX:PYFA's EV-to-EBIT is ranked worse than
100% of 688 companies
in the Drug Manufacturers industry
Industry Median: 16.935 vs ISX:PYFA: -62.87

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PT Pyridam Farma Tbk's Enterprise Value for the quarter that ended in Dec. 2024 was Rp5,873,188 Mil. PT Pyridam Farma Tbk's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was Rp-96,638 Mil. PT Pyridam Farma Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -1.65%.

PT Pyridam Farma Tbk EV-to-EBIT Historical Data

The historical data trend for PT Pyridam Farma Tbk's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Pyridam Farma Tbk EV-to-EBIT Chart

PT Pyridam Farma Tbk Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

Get a 7-Day Free Trial

17.23

18.61

3.53

572.41

-60.78

PT Pyridam Farma Tbk Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial															572.41	-56.66	-100.40	-64.43	-60.78

Competitive Comparison of PT Pyridam Farma Tbk's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, PT Pyridam Farma Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Pyridam Farma Tbk's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Pyridam Farma Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Pyridam Farma Tbk's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

PT Pyridam Farma Tbk EV-to-EBIT Calculation

PT Pyridam Farma Tbk's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	6075448.834	/	-96638.115
	=	-62.87

PT Pyridam Farma Tbk's current Enterprise Value is Rp6,075,449 Mil.
PT Pyridam Farma Tbk's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-96,638 Mil.

PT Pyridam Farma Tbk (ISX:PYFA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PT Pyridam Farma Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 )	=	EBIT	/	Enterprise Value (Q: Dec. 2024 )
	=	-96638.115	/	5873187.85
	=	-1.65 %

PT Pyridam Farma Tbk's Enterprise Value for the quarter that ended in Dec. 2024 was Rp5,873,188 Mil.
PT Pyridam Farma Tbk's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-96,638 Mil.

PT Pyridam Farma Tbk EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PT Pyridam Farma Tbk's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Pyridam Farma Tbk Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Pyridam Farma Tbk (ISX:PYFA) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jl. Gen. Sudirman No. Kav. 21, Sinarmas MSIG Tower Lt. 12, RT.10/RW.1, Kuningan, Karet, Setiabudi District, South Jakarta City, Jakarta, IDN, 12920

Website

https://www.pyfa.co.id

PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical Products and Toll Manufacturing Services; and Medical Device Products. The company derives maximum revenue from Pharmaceutical Products and Toll Manufacturing Services. The company's products include consumer health, Derma, prescription, and biomedilab.

PT Pyridam Farma Tbk Headlines

No Headlines